Orange Book product · Generic (ANDA)
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
At a glance
Oct 06, 2010
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 06, 2010
15 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
LOSARTAN POTASSIUM
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 078232
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LOSARTAN POTASSIUM
- 2025ARBLIBrand (NDA)
NDA 218772 · SCIENTURE
- 1995COZAARBrand (NDA)
NDA 020386 · ORGANON
- 2025LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 219859 · GRAVITI PHARMS
- 2024LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 218551 · APOTEX
- 2023LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 217396 · MSN
- 2023LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 215959 · GRANULES
- 2019LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 204795 · HISUN PHARM HANGZHOU
- 2015LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 203030 · UNICHEM
- 2015LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 203835 · HETERO LABS LTD V
- 2013LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 200290 · IPCA LABS LTD
- 2012LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 091541 · MICRO LABS
- 2012LOSARTAN POTASSIUMGeneric (ANDA)
ANDA 201170 · JUBILANT CADISTA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
